> top > docs > PubMed:3921456

PubMed:3921456 JSONTXT

Recombinant human interleukin 2 acts as a B cell growth and differentiation promoting factor. Human B cells appropriately activated by a B cell mitogen are rendered susceptible to human Interleukin 2 (IL-2) as demonstrated with recombinant human IL-2 (rec. h IL-2). They show increased proliferation and drastically enhanced immunoglobulin secretion. Susceptibility to IL-2 is accompanied with the expression of the IL-2 receptor (Tac antigen) on B cells. The data suggest that IL-2 is one of the lymphokines directly involved in the activation of B lymphocytes.

projects that include this document

Unselected / annnotation Selected / annnotation
spacy-test 97 (97) oger-json-test 387 (387) Allie 0 (0)